期刊文献+

Rutaecarpine Inhibits Intimal Hyperplasia in A Balloon-Injured Rat Artery Model 被引量:2

Rutaecarpine Inhibits Intimal Hyperplasia in A Balloon-Injured Rat Artery Model
原文传递
导出
摘要 Objective: To investigate the effect and potential mechanisms of rutaecarpine (Rut) in a rat artery balloon-injury model. Methods: The intimal hyperplasia model was established by rubbing the endothelia with a balloon catheter in the common carotid artery (CCA) of rats. Fifty rats were randomly divided into five groups, ie. sham, model, Rut (25, 50 and 75 mg/kg) with 10 rats of each group. The rats were treated with or without Rut (25, 50, 75 mg/kg) by intragastric administration for 14 consecutive days following injury. The morphological changes of the intima were evaluated by hematoxylin-eosin staining. The expressions of proliferating cell nuclear antigen (PCNA) and smooth muscle (SM) oL-actin in the ateries were assayed by immunohistochemical staining. The mRNA expressions of c-myc, extracellular signal-regulated kinase 2 (ERK2), MAPK phosphatase-1 (MKP-1) and endothelial nitric oxide synthase (eNOS) were determined by real-time reverse chain reaction. The protein expressions of MKP-1 and phosphorylated ERK2 (p-ERK2) were examined by Western blotting. The plasma contents of nitric oxide (NO) and cyclic guanosine 3',5'-monophosphate (cGMP) were also determined. Results: Compared with the model group, Rut treatment significantly decreased intimal thickening and ameliorated endothelial injury (P〈0.05 or P〈0.01). The positive expression rate of PCNA was decreased, while the expression rate of SM α -actin obviously increased in the vascular wall after Rut (50 and 75 mg/kg) administration (P〈0.05 or P〈0.01). Furthermore, the mRNA expressions of c-myc, ERK2 and PCNA were downregulated while the expressions of eNOS and MKP-1 were upregulated (P〈0.05 or P〈0.01). The protein expressions of MKP-1 and the phosphorylation of ERK2 were upregulated and downragulated after Rut (50 and 75 mg/kg) administration (P〈0.05 or P〈0.01), respectively. In addition, Rut dramatically reversed balloon injury-induced decrease of NO and cGMP in the plasma (P〈0.05 or P〈0.01). Conclusion: Rut could inhibit the balloon injury-induced carotid intimal hyperplasia in rats, possibly mediated by promotion of NO production and inhibiting ERK2 signal transduction pathways. Objective: To investigate the effect and potential mechanisms of rutaecarpine (Rut) in a rat artery balloon-injury model. Methods: The intimal hyperplasia model was established by rubbing the endothelia with a balloon catheter in the common carotid artery (CCA) of rats. Fifty rats were randomly divided into five groups, ie. sham, model, Rut (25, 50 and 75 mg/kg) with 10 rats of each group. The rats were treated with or without Rut (25, 50, 75 mg/kg) by intragastric administration for 14 consecutive days following injury. The morphological changes of the intima were evaluated by hematoxylin-eosin staining. The expressions of proliferating cell nuclear antigen (PCNA) and smooth muscle (SM) oL-actin in the ateries were assayed by immunohistochemical staining. The mRNA expressions of c-myc, extracellular signal-regulated kinase 2 (ERK2), MAPK phosphatase-1 (MKP-1) and endothelial nitric oxide synthase (eNOS) were determined by real-time reverse chain reaction. The protein expressions of MKP-1 and phosphorylated ERK2 (p-ERK2) were examined by Western blotting. The plasma contents of nitric oxide (NO) and cyclic guanosine 3',5'-monophosphate (cGMP) were also determined. Results: Compared with the model group, Rut treatment significantly decreased intimal thickening and ameliorated endothelial injury (P〈0.05 or P〈0.01). The positive expression rate of PCNA was decreased, while the expression rate of SM α -actin obviously increased in the vascular wall after Rut (50 and 75 mg/kg) administration (P〈0.05 or P〈0.01). Furthermore, the mRNA expressions of c-myc, ERK2 and PCNA were downregulated while the expressions of eNOS and MKP-1 were upregulated (P〈0.05 or P〈0.01). The protein expressions of MKP-1 and the phosphorylation of ERK2 were upregulated and downragulated after Rut (50 and 75 mg/kg) administration (P〈0.05 or P〈0.01), respectively. In addition, Rut dramatically reversed balloon injury-induced decrease of NO and cGMP in the plasma (P〈0.05 or P〈0.01). Conclusion: Rut could inhibit the balloon injury-induced carotid intimal hyperplasia in rats, possibly mediated by promotion of NO production and inhibiting ERK2 signal transduction pathways.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2018年第6期429-435,共7页 中国结合医学杂志(英文版)
基金 Supported by National Natural Science Foundation of China(No.81160528) Administration of Traditional Chinese Medicine of Guizhou Province foundation,China(No.2009-79)
关键词 RUTAECARPINE balloon-injury intimal hyperplasia extracellular signal-regulated kinase 2 nitric oxide rutaecarpine balloon-injury intimal hyperplasia extracellular signal-regulated kinase 2 nitric oxide
  • 相关文献

参考文献1

二级参考文献29

  • 1Bao MH, Dai W, Li YJ, Hu CP. Rutaecarpine prevents hypoxia-reoxygenation-induced myocardial cell apoptosis via inhibition of NADPH oxidases. Can J Physiol Pharmacol 2011 ;89:177-186.
  • 2Liao JF, Chfou WF, Shen YC, Wang G J, Chen CF. Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components. Chin Med 2011 ;6:6-13.
  • 3Deng PY, Ye F, Cai W J, Tan GS, Hu CP, Deng HW, et al. Stimulation of calcitonin gene-related peptide synthesis and release: mechanisms for a novel antihypertensive drug, rutaecarpine. J Hypertens 2004;22:1819-1829.
  • 4Qin XP, Zeng SY, Li D, Chen QQ, Luo D, Zhang Z, et al. Calcitonin gene-related peptide-med(ated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats. J Cardiovasc Pharmacol 2007;50:654-659.
  • 5Chiou WF, Liao JF, Chen CF. Comparative study of the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J Nat Prod 1996;59:374-378.
  • 6Hung WW, Hsieh T J, Lin T, Chou PC, Hsiao P J, Lin KD, et al. Blockade of the renin-angiotensin system ameliorates apelin production in 3T3-L1 adipocytes. Cardiovasc Drugs Ther 2011 ;25:3-12.
  • 7Touyz RM. The role of angiotensin Ⅱ in regulating vascularstructural and functional changes in hypertension. Curr Hypertens Rep 2003;5:155-164.
  • 8Alvin Z, Laurence GG, Coleman BR, Zhao A, Hajj-Moussa M, Haddad GE. Regulation of L-type inward calcium channel activity by captopril and angiotensin 1I via the phosphatidyl inositol 3-kinase pathway in cardiomyocytes from volume-overload hypertrophied rat hearts. Can J Physiol Pharmacol 2011 ;89:206-215.
  • 9Ruiz-Ortega M, Ruperez M, Esteban V, Egido J. Molecular mechanisms of angiotensin I] -induced vascular injury. Curr Hypertens Rep 2003;5:73-79.
  • 10Suzuki H, Motley ED, Frank GD, Utsunomiya H, Eguchi S. Recent progress in signal transduction research of the angiotensin ]] type-1 receptor: protein kinases, vascular dysfunction and structural requirement. Curr Med Chem Cardiovasc Hematol Agents 2005;3:305-322.

共引文献14

同被引文献15

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部